Posted on November 09 2010
 |
Conventional chemotherapy drugs modestly improve cancer survival rates, but many cause notable side effects. Recently, a study founded by Morris Animal Foundation found Metronomic therapy, a new way of administering chemotherapy that involves frequent, low-level doses of chemotherapy rather than higher doses at longer intervals, may improve dogs’ treatment response and decrease side effects. Researchers studied whether metronomic dosing of the drug cyclophosphamide is safe and effective in treating dogs with soft-tissue sarcomas.
The post Improved Treatment for Dogs with Soft Tissue Cancer appeared first on Orvis News.